Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
5,850.00
145.95 (2.56%)
BSENSE

Oct 09

BSE+NSE Vol: 9.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAstrazeneca Phar VS Pharmaceuticals & Biotechnology
 
1D
2.56%
1.23%
1W
-2.99%
0.78%
1M
-15.21%
-3.07%
YTD
-35.07%
-14.96%
1Y
-36.67%
-11.8%
3Y
25.46%
10.62%
5Y
87.09%
20.67%
10Y
518.69%
158.27%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.63%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.88%
0.43%
-27.45%
6 Months
-27.38%
0.41%
-26.97%
1 Year
-36.67%
0.39%
-36.28%
2 Years
-25.61%
0.92%
-24.69%
3 Years
25.46%
2.00%
27.46%
4 Years
87.94%
3.27%
91.21%
5 Years
87.09%
3.83%
90.92%

Latest dividend: 35.83219514591726 per share ex-dividend date: Jul-31-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-5.49%
4
Quartile
quartile-4
Jun-Sep
-24.66%
4
Quartile
quartile-4
Mar-Jun
5.88%
4
Quartile
quartile-4
YTD
-36.91%
1
Quartile
quartile-1
2025
22.84%
4
Quartile
quartile-4
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-5.49%
4
Quartile
quartile-4
Jun-Sep
-24.66%
4
Quartile
quartile-4
Mar-Jun
5.88%
4
Quartile
quartile-4
YTD
-36.91%
1
Quartile
quartile-1
2025
22.84%
3
Quartile
quartile-3
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-5.49%
4
Quartile
quartile-4
Jun-Sep
-24.66%
4
Quartile
quartile-4
Mar-Jun
5.88%
4
Quartile
quartile-4
YTD
-36.91%
1
Quartile
quartile-1
2025
22.84%
2
Quartile
quartile-2
2024
32.88%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available